Dr.Reddys Laboratories reported INR74.58B in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Aspen Pharmacare ZAR 13.32B 5.36B Dec/2025
Bharat Petroleum INR 1.09T 121.78B Dec/2025
Cipla INR 59.27B 1.71B Mar/2026
Dr.Reddys Laboratories INR 74.58B 977M Mar/2026
Sun Pharmaceuticals INR 114.07B 2.96B Dec/2025
UPL INR 156.03B 49.4B Mar/2026